Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
LuxQuanta capta 8 M€ para desplegar soluciones de ciberseguridad cuántica.
Esta spin-off del ICFO se basa en la investigación liderada por el investigador ICREA Valerio Pruneri, que también es miembro…
Premios Nacionales de Investigación 2025
Tres Profesores de Investigación ICREA han recibido el Premio Nacional de Investigación 2025. Felicidades a: · Josep Dalmau (FRCB-IDIBAPS) Premio…